Endocare liver cancer cryoablation
This article was originally published in The Gray Sheet
Accepted for reimbursement in 15 states, including New York, California, Texas and Illinois, the company announces Sept. 22. Endocare continues discussions to expand coverage to more states for the procedure, which is intended to target, freeze, and eliminate liver cancers
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.